Pan-Viral Screening and Linkage to Care Among GBMSM and Trans Women in Spain

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
HIVHepatitis BHepatitis C
Interventions
DIAGNOSTIC_TEST

Online self-sampling testing strategy to enhance pan-viral testing (HBV, HCV, HIV)

"The TESTATE website (https://testate.org/) will be expanded to include the offer of free HBV/HCV/HIV self-sampling kit. Users will log in and complete a sociodemographic, behavioral and hepB vaccination survey, which will include the HCVMOSAIC questionnaire. Users identified at HCV risk will be sent a DBS collection kit by post to detect HCV RNA, HBsAg and HIV Ab. Participants will self-collect the DBS sample by finger prick at home and send them to the laboratory by post. The results will be delivered online. All participants who return samples will receive an acceptance survey by email.~All participants recruited into the study will be provided with online information about the study and given the opportunity to ask questions and clarify queries to the field coordinator by email or phone."

All Listed Sponsors
lead

Fundació Institut Germans Trias i Pujol

OTHER

NCT07085715 - Pan-Viral Screening and Linkage to Care Among GBMSM and Trans Women in Spain | Biotech Hunter | Biotech Hunter